Aspen Aerogels (ASPN) Common Equity (2013 - 2026)

Aspen Aerogels has reported Common Equity for 14 years, with the latest figure at $213.5 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 32.19% year-over-year to $213.5 million; the trailing twelve-month figure through Mar 2026 stood at $213.5 million (down 32.19% YoY), and the FY2025 full-year result was $235.5 million, down 61.69% from the prior year.
• Common Equity for Q1 2026 stood at $213.5 million, down from $235.5 million in the prior quarter.
• The five-year high for Common Equity was $614.7 million in Q4 2024, with the low at $164.8 million in Q2 2022.
• Historically, Common Equity has averaged $366.8 million across 5 years, with a median of $409.8 million in 2023.
• Annual changes were most pronounced in 2022 — Common Equity jumped 248.45% — and 2025, when it slumped 61.69%.
• Aspen Aerogels' Common Equity stood at $447.4 million in 2022, then climbed by 9.08% to $488.1 million in 2023, then rose by 25.95% to $614.7 million in 2024, then tumbled by 61.69% to $235.5 million in 2025, then slipped by 9.35% to $213.5 million in 2026.
• The last three Common Equity figures came in at $213.5 million (Q1 2026), $235.5 million (Q4 2025), and $305.7 million (Q3 2025), per Business Quant data.